Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1554.00Today’s High
1642.6052W low
907.2052W High
1740.00Open Price
1576.00Prev. Close
1450.1500Volume
23903.00Value
38902132.50Fundamentals
Market Cap Cr
2691.70
Price to Earnings
30.70
Price to Book Value
7.20
Dividend Yield
1.70
PE to Growth
1.00
Op Revenue TTM Cr
582.05
Net Profit TTM Cr
87.66
Cash From Operating Activity Cr
94.36
Return on Equity %
23.38
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
57.7
Week
45.5
Month
50.4
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1575.82
PIVOT
First Resistance
1594.43
Second Resistance
1619.67
Third Resistance
1638.28
First Support
1550.58
Second Support
1531.97
Third Support
1506.73
Relative Strength Index
52.99
Money Flow Index
52.33
MACD
29.63
MACD Signal
28.81
Average True Range
56.47
Average Directional Index
28.45
Rate of Change (21)
12.24
Rate of Change (125)
16.67
Commodity Channel Index
24
Williams %R
-69.4
BETA
1 Month
0.45
3 Month
0.41
1 Year
0.34
3 Year
0.17
PRICE CHANGE ANALYSIS
↑ 1.14%
1 Week
Low
High
1554.05
1665.9
↑ 16.41%
1 Month
Low
High
1382
1692
↑ 4.49%
3 Months
Low
High
1381
1692
↑ 16.26%
6 Months
Low
High
1360
1740
↑ 72.37%
1 Year
Low
High
907.2
1740
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 128.64 | 155.62 | 155.41 | 149.59 | 120.33 | 131.11 | 136.02 | 130.15 | 105.06 | 116.19 | 113.36 | |
| Operating Expenses Qtr | 106.27 | 115.80 | 116.29 | 115.54 | 102.58 | 101.39 | 105.06 | 101.09 | 90.29 | 91.48 | 86.85 | |
| Operating Profit Qtr | 20.72 | 37.90 | 37.29 | 32.24 | 15.91 | 29.21 | 29.73 | 27.84 | 13.51 | 24.10 | 25.80 | |
| EBIDT Qtr Cr | 22.37 | 39.82 | 39.12 | 34.05 | 17.75 | 29.72 | 30.96 | 29.06 | 14.77 | 24.71 | 26.51 | |
| Depreciation Qtr | 4.49 | 4.14 | 4.23 | 4.21 | 3.89 | 3.91 | 3.87 | 3.83 | 3.78 | 3.93 | 3.99 | |
| Net Profit Qtr | 13.24 | 26.46 | 25.86 | 22.10 | 10.35 | 19.11 | 19.97 | 18.21 | 7.52 | 14.63 | 15.75 | |
| Basic EPS Qtr | 8.01 | 16.00 | 15.64 | 13.36 | 6.26 | 11.56 | 12.08 | 11.01 | 4.55 | 8.85 | 9.52 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 589.26 | 517.61 | 443.15 | 390.05 | 376.30 | |
| Operating Expenses Annual Cr | 453.90 | 410.12 | 353.80 | 319.21 | 316.42 | |
| Operating Profit Annual | 128.15 | 102.69 | 86.36 | 69.93 | 59.15 | |
| Operating Profit Margin Annual % | 21.75 | 19.84 | 19.49 | 17.93 | 15.72 | |
| Total Expenses Annual Cr | 471.42 | 425.93 | 369.98 | 336.47 | 334.53 | |
| EBIDT Annual Cr | 135.36 | 107.49 | 89.35 | 70.84 | 59.88 | |
| EBIDT Annual margin % | 22.97 | 20.77 | 20.16 | 18.16 | 15.91 | |
| Depreciation | 17.07 | 15.50 | 15.66 | 16.47 | 16.36 | |
| PAT Before ExtraOrdinary Items Annual Cr | 87.66 | 67.64 | 51.48 | 40.00 | 29.01 | |
| Net Profit Annual | 87.66 | 67.64 | 51.48 | 40.00 | 29.01 | |
| Basic EPS Annual | 53.01 | 40.90 | 31.13 | 24.19 | 17.54 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 374.85 | 307.60 | 255.77 | 216.45 | 176.57 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 7.06 | 8.97 | 8.73 | 7.25 | 7.57 | |
| Total Current Liabilities Annual Cr | 130.96 | 102.78 | 80.11 | 79.69 | 82.59 | |
| Total Capital Plus Liabilities Annual Cr | 512.87 | 419.35 | 344.61 | 303.39 | 266.73 | |
| Fixed Assets Annual | 209.84 | 149.70 | 134.77 | 125.07 | 132.87 | |
| Total Non Current Assets Annual | 214.78 | 155.30 | 137.70 | 127.54 | 140.95 | |
| Total Current Assets Annual | 298.09 | 264.05 | 206.91 | 175.85 | 125.78 | |
| Total Assets Annual | 512.87 | 419.35 | 344.61 | 303.39 | 266.73 | |
| Contingent Liabilities plus Commitments Annual Cr | 22.26 | 33.52 | 15.12 | 16.98 | 14.20 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 94.36 | 90.82 | 64.75 | 58.27 | 50.17 | |
| Cash from Investing Activity Annual | -79.15 | -105.81 | -34.66 | -7.96 | -10.70 | |
| Cash from Financing Annual Activity | -20.31 | -17.13 | -13.51 | -10.49 | -39.30 | |
| Net Cash Flow Annual | -5.10 | -32.12 | 16.58 | 39.82 | 0.17 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 226.67 | 186.00 | 154.66 | 130.88 | 106.77 | |
| ROE Annual % | 23.38 | 21.98 | 20.12 | 18.48 | 16.42 | |
| ROCE Annual % | 30.97 | 29.05 | 27.86 | 24.30 | 23.63 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 | |
| EBDIT Annual Margin % | 23.25 | 20.96 | 20.29 | 18.20 | 15.94 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Nucleus Life Trust (Mr. Harsh Vardhan Goenka is a Trustee) | 53.8 | 75070196 | 0 | 0 |
| Ektara Enterprises LLP | 15.57 | 75070197 | 0 | 0 |
| STEL Holdings Limited | 3.18 | 75070198 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Mirae Asset Multicap Fund | 1.42 | 75070216 |
| Authum Investment And Infrastructure Limited | 2.02 | 75070220 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HUF | 0.87 | 75070227 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jun 28, 2024 | 16 | FINAL | Jun 28, 2024 | Equity Share |
| Jul 21, 2023 | 12 | FINAL | Jul 21, 2023 | Equity Share |
| Jul 14, 2022 | 9.6 | FINAL | Jul 15, 2022 | Equity Share |
| Aug 13, 2021 | 7.2 | FINAL | Aug 17, 2021 | Equity Share |
| Mar 24, 2020 | 4 | INTERIM | Mar 26, 2020 | Equity Share |
| Jul 22, 2019 | 2.4 | FINAL | - | Equity Share |
| Jul 19, 2018 | 2.4 | FINAL | - | Equity Share |
| Jul 13, 2017 | 2.8 | FINAL | - | Equity Share |
| Mar 22, 2016 | 1.6 | INTERIM | Mar 24, 2016 | Equity Share |
| Jul 20, 2015 | 0.8 | FINAL | - | Equity Share |
| Sep 11, 2014 | 0.8 | SPECIAL | - | Equity Share |
| Sep 11, 2014 | 1.2 | FINAL | - | Equity Share |
| Jul 11, 2013 | 1.2 | FINAL | - | Equity Share |
| Jul 24, 2012 | 0.8 | FINAL | - | Equity Share |
| Jul 14, 2011 | 1.6 | FINAL | - | Equity Share |
| Jul 15, 2010 | 1.44 | FINAL | - | Equity Share |
| Jul 30, 2009 | 1.2 | FINAL | - | Equity Share |
| Aug 11, 2008 | 1.2 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| Apr 30, 2024 | Audited Results & Final Dividend | - |
| Feb 01, 2024 | Quarterly Results | - |
| Oct 18, 2023 | Quarterly Results | - |
| Jul 28, 2023 | Quarterly Results | - |
| Apr 28, 2023 | Audited Results & Final Dividend | - |
| Feb 01, 2023 | Quarterly Results | - |
| Oct 17, 2022 | Quarterly Results | - |
| Aug 02, 2022 | Quarterly Results | - |
| Apr 29, 2022 | Audited Results | - |
| Jan 25, 2022 | Quarterly Results | - |
| Oct 29, 2021 | Quarterly Results | - |
| Jul 28, 2021 | Quarterly Results | - |
| Apr 30, 2021 | Audited Results | - |
| Jan 25, 2021 | Quarterly Results | - |
| Oct 30, 2020 | Quarterly Results | - |
| Jul 31, 2020 | Quarterly Results | - |
| Jun 05, 2020 | Audited Results | - |
| Mar 18, 2020 | Interim Dividend | - |
| Jan 31, 2020 | Quarterly Results | - |
| Oct 30, 2019 | Quarterly Results | - |
| Jul 30, 2019 | Quarterly Results | - |
| Apr 29, 2019 | Audited Results & Final Dividend | - |
| Feb 05, 2019 | Quarterly Results | - |
| Nov 05, 2018 | Quarterly Results | - |
| Jul 27, 2018 | Quarterly Results | - |
| May 02, 2018 | Audited Results & Dividend | - |
| Feb 02, 2018 | Quarterly Results | - |
| Nov 10, 2017 | Quarterly Results | - |
| Aug 04, 2017 | Quarterly Results | - |
| Apr 28, 2017 | Audited Results & Dividend | - |
| Feb 01, 2017 | Quarterly Results | - |
| Oct 21, 2016 | Quarterly Results | - |
| Jul 27, 2016 | Quarterly Results | Approved the acquisition of Trade Marks from Sun Pharmaceutical Industries Limited and its subsidiary. |
| Apr 29, 2016 | Audited Results & Final Dividend | Board of Directors of the Company at its meeting held on April 26, 2016 has not recommended any dividend. |
| Mar 14, 2016 | Interim Dividend | - |
| Feb 02, 2016 | Quarterly Results | - |
| Oct 29, 2015 | Quarterly Results | Resignation of Ms. Neera Saggi from the Directorship of the Company with immediate effect due to her pre-occupation. |
| Jul 28, 2015 | Quarterly Results | - |
| Apr 29, 2015 | Audited Results & Dividend | - |
| Jan 23, 2015 | Quarterly Results | - |
| Oct 20, 2014 | Quarterly Results | - |
| Jul 24, 2014 | Quarterly Results | - |
| Apr 30, 2014 | Audited Results & Dividend | - |
| Feb 07, 2014 | Quarterly Results | - |
| Oct 18, 2013 | Quarterly Results | - |
| Jul 26, 2013 | Quarterly Results | - |
| May 07, 2013 | Audited Results & Dividend | - |
| Feb 06, 2013 | Quarterly Results | - |
| Oct 23, 2012 | Quarterly Results | - |
| Aug 09, 2012 | Quarterly Results | - |
| Apr 27, 2012 | Audited Results & Dividend | - |
| Jan 23, 2012 | Quarterly Results | - |
| Oct 19, 2011 | Quarterly Results | - |
| Jul 28, 2011 | Quarterly Results | - |
| Apr 28, 2011 | Audited Results & Dividend | - |
| Jan 17, 2011 | Quarterly Results | - |
| Oct 20, 2010 | Quarterly Results | - |
| Jul 29, 2010 | Quarterly Results | - |
| May 12, 2010 | Audited Results & Dividend | - |
| Jan 19, 2010 | Quarterly Results | - |
| Oct 28, 2009 | Quarterly Results | - |
| Jul 29, 2009 | Quarterly Results | - |
| Jun 25, 2009 | Audited Results & Dividend | - |
| Feb 20, 2009 | To issue of Convertible Warrants | To issue of 15,00,000 convertible warrants to Petrochem International Ltd & 6,38,000 convertible warrants to KEC Holdings Ltd, both Promoter Group Co's, on preferential basis. |
| Jan 29, 2009 | Quarterly Results | - |
| Oct 23, 2008 | Quarterly Results | - |
| Jul 31, 2008 | Quarterly Results | - |
| Jun 30, 2008 | Audited Results & Dividend | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
27 Jun 2024
RPG LIFE SCIENCES LTD. - 532983 - Closure of Trading Window
Company has informed the exchanges about closure of Trading Window of the Company pursuant to provisions of SEBI (LODR) Regulations, 2015, for declaration of unaudited financial results for the quarter ending on June 30, 2024.
25 Jun 2024
RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication
The Company informs exchanges about the Newspaper Publication
24 Jun 2024
RPG LIFE SCIENCES LTD. - 532983 - Business Responsibility and Sustainability Reporting (BRSR)
This is further to our letter dated June 11, 2024, conveying that the 17th AGM of the Company is scheduled on Tuesday, July 16, 2024 through VC/ OAVM mode. Pursuant to Regulation 34(1) and Regulation 30(2) of SEBI (LODR) Regulations, 2015, we are hereby submitting the Annual Report along with the Business Responsibility and Sustainability Report for the financial year 2023-24.
24 Jun 2024
RPG LIFE SCIENCES LTD. - 532983 - Reg. 34 (1) Annual Report.
This is further to our Letter dated June 11, 2024, conveying that the 17th AGM of the Company will be held on Tuesday, July 16, 2024 at 03.00 p.m. through VC/OAVM mode. Pursuant to Regulation 34 of SEBI (LODR) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2023-24.
24 Jun 2024
RPG LIFE SCIENCES LTD. - 532983 - Notice Of Seventeenth Annual General Meeting, Annual Report FY 2023-24 And The Business Responsibility And Sustainability Report
This is further to our letter dated June 11, 2024, conveying that the 17th Annual General Meeting of the Members of RPG Life Sciences Limited will be held on Tuesday, July 16, 2024 at 03.00. p.m. (IST) through VC/OAVM. Pursuant to Regulation 34(1) and Regulation 30(2) of SEBI (LODR) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2023-24 along with Notice of the ensuing 17th Annual General Meeting.
14 Jun 2024
RPG LIFE SCIENCES LTD. - 532983 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Company has informed Exchanges about details of Issue of Duplicate Certificate.
14 Jun 2024
RPG LIFE SCIENCES LTD. - 532983 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Company has informed Exchanges about intimation of Loss of share certificate as received from Link Intime India Private Limited.
12 Jun 2024
RPG LIFE SCIENCES LTD. - 532983 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
RPG Life Sciences Limited has informed the Company about Intimation of Loss of Share certificate as received from Link Intime India Private Limited
12 Jun 2024
RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication
RPG Life Sciences Ltd. has informed the Company about the Newspaper advertisement regarding Record date of 17th AGM
11 Jun 2024
RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Company informs exchange about the Investor/Analyst Meeting Scheduled on June 18, 2024.
